Propylthiouracil reduces xenograft tumor growth in an athymic nude mouse prostate cancer model

American Journal of the Medical Sciences

Volumn 319, Issue 2, 2000, Pages 96-99

  Theodossiou, Chris ^a   Schwarzenberger, Paul ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Hypothyroidism; Propylthiouracil; Prostate cancer

Indexed keywords

PROPYLTHIOURACIL; THYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFECT; HORMONAL THERAPY; HYPOTHYROIDISM; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PROSTATE CANCER; TUMOR GROWTH; TUMOR XENOGRAFT;

EID: 0034040640     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9629(15)40695-0     Document Type: Article

References (29)

1. Hercbergs A, Leith J. Spontaneous remission of metastatic lung cancer following myxedema coma - an apoptosis-related phenomenon? J Nat Cancer Inst 1993;85:1342-3.
2. Hercbergs A, Prescott J, Bouer L. Thyroid disease (TD) and prognosis in metastatic renal cell carcinoma (RCC) [abstract]. Proc Am Soc Clin Oncol 1993:12:242.
3. Hercbergs A. Hypothyroidism and tumor regression. N Engl J Med 1989;329:1351-2.
4. Hercbergs A, Werner A, Brenner HJ. Does hypothyroidism favor the response to therapy in metastatic breast cancer [abstract]? Proc Am Soc Clin Oncol 1998;7:30.
5. Shoemaker JP, Dagher RK. Remissions of mammary adenocarcinoma in hypothyroid mice given 5-fluorouracil and chloroquine phosphate. J Natl Cancer Inst 1979;62:1575-78.
6. Kumar MS, Chiang T, Deedhar SD. Enhancing effect of thyroxine on tumor growth and metastases in syngeneic mouse tumor systems. Cancer Res 1979;39:3515-8.
7. Mason RM, Bansal MK. Different growth rates of swarm chondrosarcoma in Lewis and Wister rats correlate with different thyroid hormone levels. Connect Tissue Res 1987; 10:177-85.
8. Leith J, Hercbergs A. Effects of modulation of thyroid function on the growth and mediation sensitivity of a human colon carcinoma (HT-29) [abstract]. Proc Am Assoc Cancer Res 1994;35:247.
9. Mishkin SY, Pollack R, Morris HP, et al. Inhibition of local and metastatic hepatoma growth and prolongation of survival after induction of hypothyroidism. Cancer Res 1981; 41:3040-5.
10. Shoemaker JP, Bradley RI, Huffman RV. Increased survival and inhibition of mammary tumors in hypothyroid mice. J Surg Res 1976;21:151-4.
11. Kaighn ME, Lechner JF, Babcock MS, et al. The Pasadena cell lines. Prog Clin Biol Res 1980;37:85-109.
12. Guerrero A, Pamplona R, Portero-Otin M, et al. Effect of thyroid status on lipid composition and peroxidation in the mouse liver. Free Radic Biol Med 1999;26:73-80.
13. Helton TE, Magner JA. β-1,4-galactosyltransferase and α-mannosidase-II messenger ribonucleic acid levels increase with different kinetics in thyrotrophs of hypothyroid mice. Endocrinology 1994;135:1980-5.
14. Helton TE, Magner JA. β-Galactoside α-2,3-sialyltransferase messenger RNA increases in thyrotrophs of hypothyroid mice. Thyroid 1995;5:315-7.
15. Jaiyesimi IA, Buzdar AU, Decker DA, et al. Use of tamoxifen for breast cancer: twenty eight years later. J Clin Oncol 1995;13:513-29.
16. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 1998;351:1451-67.
17. Newling DW, Dennis L, Vermeylen K. Orchiectomy versus goserelin and flutamide in the treatment of newly diagnosed metastatic prostate cancer. Cancer 1993;72 (suppl): 3793-98.
18. Scher HI, Liebertz C, Kelly WK, et al. Bicalutamide for advanced prostate cancer: the natural versus treated history of disease. J Clin Oncol 1997;15:2928-38.
19. Fair WR, Scher HI. Neoadjuvant hormonal therapy plus surgery for prostate cancer. Surg Clin North Am 1997;6:831-46.
20. Andron AE, Danesghari F, Crawford ED. Neoadjuvant hormonal therapy in stage C adenocarcinoma of the prostate. Clin Invest Med 1993;16:510-5.
21. Cox RL, Crawford ED. Estrogens in the treatment of prostate cancer. J Urol 1995;154:1991-2003.
22. Kasayama S, Yoshimura M, Ohm T. The regulation by thyroid hormones and androgen of epithelial growth factor messenger ribonucleic acid and circulating levels in the rat. J Endocrinol 1989;121:269-75.
23. Wolf M, Inebar S, Moses AC. Thyroid hormone and growth hormone interact to regulate insulin-like growth factor messenger ribonucleic acid and circulating levels in the rat. Endocrinology 1989;125:2905-14.
24. Black MA, Pope L, Lefebyte FA, et al. Thyroid hormones precociously increase nerve growth factor gene expression in the submandibular gland of neonatal mice. Endocrinology 1992;130:2083-90.
25. Mulvei A, Anderson G, Nelson BD. Thyroid hormone and not growth hormone is the principal regulator of mammalian mitochondrial mitogenesis. Acta Endocrinol 1989;121:223-38.
26. Nunez J, Gauchio D, Aniello F, et al. Regulation by thyroid hormone of microtubule assembly and neuronal differentiation. Neurochem Res 1991;16:975-82.
27. Arnaout MA, Awieli AS, el-Najdawi AM, et al. Arginine-vasopressin and endothelium-associated proteins in thyroid disease. Acta Endocrinologica 1992;126:399-403.
28. Satav JG, Katyare SS. Thyroid hormones and cathepsin D activity in the rat liver, kidney, and brain. Experientia 1981; 37:100-103.
29. Vogelzang NJ. One hundred thirteen men with hormone-refractory prostate cancer died today. J Clin Oncol 1996;14: 1753-5.